1. Home
  2. SO vs BSX Comparison

SO vs BSX Comparison

Compare SO & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southern Company (The)

SO

Southern Company (The)

HOLD

Current Price

$93.73

Market Cap

101.3B

Sector

Utilities

ML Signal

HOLD

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$69.44

Market Cap

103.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SO
BSX
Founded
1945
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Power Generation
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
101.3B
103.6B
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
SO
BSX
Price
$93.73
$69.44
Analyst Decision
Hold
Strong Buy
Analyst Count
17
20
Target Price
$98.78
$107.85
AVG Volume (30 Days)
5.3M
10.7M
Earning Date
04-30-2026
04-22-2026
Dividend Yield
3.08%
N/A
EPS Growth
N/A
55.20
EPS
N/A
1.94
Revenue
N/A
$9,076,000,000.00
Revenue This Year
$8.18
$12.02
Revenue Next Year
$5.61
$10.41
P/E Ratio
$22.63
$36.28
Revenue Growth
N/A
12.49
52 Week Low
$83.80
$67.56
52 Week High
$100.84
$109.50

Technical Indicators

Market Signals
Indicator
SO
BSX
Relative Strength Index (RSI) 42.70 35.18
Support Level $92.84 $67.56
Resistance Level $96.17 $76.77
Average True Range (ATR) 1.65 1.89
MACD -0.56 0.43
Stochastic Oscillator 7.08 24.86

Price Performance

Historical Comparison
SO
BSX

About SO Southern Company (The)

Southern is one of the largest utilities in the US. The company serves 9 million customers with vertically integrated electric utilities in three states and natural gas distribution utilities in four states. It owns 44 gigawatts of rate-regulated generating capacity, primarily for serving customers in Georgia, Alabama, and Mississippi. Subsidiary Southern Power owns 13 gigawatts of natural gas generation and renewable energy across the US and sells the electricity primarily under long-term contracts.

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: